We suggest that up-regulation of c-Myc in rectal cancer cells results in a markedly increased sensitivity to apoptosis induced by fluoropyrimidine capecitabine which is enzymatically converted to 5-FU in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Here, MYC is linked to rectal cancer.